logo
Health professionals' skills to detect benign tumours drop after using AI for 3 months, study finds

Health professionals' skills to detect benign tumours drop after using AI for 3 months, study finds

The Hindua day ago
Frequent reliance on artificial intelligence may lead to the risk of losing skills, as indicated by a study that discovered a 20% decrease in the ability of experienced health professionals to detect benign tumour growths in colonoscopies when not using AI.
Researchers from Poland, Norway, Sweden, and other European nations examined more than 1,400 colonoscopies — approximately 800 were conducted without AI assistance, while 650 utilised AI during the procedure. A colonoscopy is used to inspect the large intestine, encompassing the colon and rectum, for disease.
The study compared colonoscopies performed three months prior to and following the integration of AI.
Three months after becoming reliant on AI for support, the detection rate of adenomas -- a non-cancerous tumour -- during standard colonoscopy decreased significantly from 28.4 per cent before to 22.4 per cent after exposure to AI, the authors stated in their study published in The Lancet Gastroenterology and Hepatology journal.
While studies have shown that using AI can help doctors and clinicians in improving cancer detection, the study is the first to "suggest a negative impact of regular AI use on healthcare professionals' ability to complete a patient-relevant task in medicine of any kind," author Marcin Romanczyk, Academy of Silesia in Poland, said.
"Our results are concerning, given that the adoption of AI in medicine is rapidly spreading. We urgently need more research into the impact of AI on health professionals' skills across different medical fields," Romanczyk said.
Author Yuichi Mori from the University of Oslo, Norway, said the results posed "an interesting question" related to previous trials, which found that an AI-assisted colonoscopy allowed for a higher tumour detection, compared to one that did not use AI's help.
"It could be the case that non-AI-assisted colonoscopy assessed in these trials is different from standard non-AI-assisted colonoscopy as the endoscopists in the trials may have been negatively affected by continuous AI exposure," Mori said.
The authors emphasised the necessity for additional research to comprehend the dynamics involved when healthcare professionals and AI systems are not effectively synchronised.
In a commentary article related to the research, Dr Omer Ahmad from University College London, who was not involved in the study, said the findings "temper the current enthusiasm for (a) rapid adoption of AI-based technologies."
The results provide the "first real-world clinical evidence for the phenomenon of deskilling, potentially affecting patient-related outcomes" and "highlight the importance of carefully considering possible unintended clinical consequences," Dr Ahmad said.
"Although AI continues to offer great promise to enhance clinical outcomes, we must also safeguard against the quiet erosion of fundamental skills required for high-quality endoscopy," the author added.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ChatGPT health scare: 60-year-old man hospitalized after following AI advice- Here's why
ChatGPT health scare: 60-year-old man hospitalized after following AI advice- Here's why

Time of India

time5 hours ago

  • Time of India

ChatGPT health scare: 60-year-old man hospitalized after following AI advice- Here's why

. A 60-year-old man was hospitalized for three weeks after replacing table salt with sodium bromide following advice from the AI chatbot ChatGPT. The case was detailed in a report published this month in the Annals of Internal Medicine by three physicians from the University of Washington. According to the report, the man had no prior psychiatric history when he arrived at the hospital "expressing concern that his neighbor was poisoning him. " He reported that he had been distilling his own water at home and appeared paranoid about the water he was offered. After lab tests and consultation with poison control, doctors found high levels of bromide in the body, as reported by NBC News. "In the first 24 hours of admission, he expressed increasing paranoia and auditory and visual hallucinations, which, after attempting to escape, resulted in an involuntary psychiatric hold for grave disability," the case report said. Once stabilized, the man revealed that he had conducted a "personal experiment" to eliminate table salt from his diet after reading about its potential health risks. He said he had consulted ChatGPT before making the change, which he followed for three months. The physicians did not have access to the man's exact ChatGPT conversation logs. However, when they asked ChatGPT 3.5 what chloride could be replaced with, the AI suggested bromide. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Use an AI Writing Tool That Actually Understands Your Voice Grammarly Install Now Undo "Though the reply stated that context matters, it did not provide a specific health warning, nor did it inquire about why we wanted to know, as we presume a medical professional would do," the report said. In a prior statement to Fox News, OpenAI the parent company has emphasized that the chatbot is not intended for treating any health condition. "We have safety teams working on reducing risks and have trained our AI systems to encourage people to seek professional guidance," the statement said. The report noted that bromide toxicity was more common in the early 1900s, when bromide salts were found in over-the-counter medications and sedatives and accounted for about 8% of psychiatric admissions. Today, bromide is primarily used in veterinary medicine as an anti-epileptic treatment for cats and dogs, according to the National Library of Medicine. The report said the syndrome is rare, but cases have recently re-emerged because bromide-containing substances have become more widely available online.

How other countries handled stray dog menace
How other countries handled stray dog menace

India Today

time7 hours ago

  • India Today

How other countries handled stray dog menace

A heated debate is raging in India over how to best deal with dog bites after the Supreme Court ordered authorities to capture and lodge canines in shelters in data from Delhi reveals that a total of 26,334 dog bite cases have been reported this year alone, as per news agency many have supported the order, animal activists want the court to review its judgement, calling the approach devoid of compassion and against the spirit of an earlier order by the So, how did other nations handle the problem of dog bites around the world? India Today takes a European nation adopted a comprehensive welfare-first strategy, including heavy taxes on pet store purchases to encourage adoption from shelters. Government funded CNVR (Collect, Neuter, Vaccinate, Return) programs providing free sterilisation and vaccination for strays, strict anti-cruelty laws with heavy penalties, and a dedicated animal welfare enforcement unit for rescues and law enforcement are some of the major initiatives. Nationwide adoption campaigns and public awareness efforts have further fostered responsible pet ownership. MOROCCO In Morocco, where approximately one lakh people are bitten by dogs every year, the government adopted a Trap-Neuter-Vaccinate-Release (TNVR) program in 2019. This humane approach involves capturing stray dogs, sterilizing and vaccinating them against rabies, and then releasing them back to their communities with identification tags specifying that they are safe. The Interior Minister of Morocco announced $100 million to tackle the growing population of stray dogs by opening 130 communal hygiene offices hiring 60 doctors, 260 nurses, 260 health technicians, and 130 veterinarians to manage animal shelters in 1244 municipalities, as per Moroccan the country has faced criticism and allegations from activists and animal rights groups accusing the government of secretly culling dogs ahead of co-hosting the 2030 FIFA World Cambodia, a significant success has been achieved through a mass dog vaccination campaign, where 2.2 lakh dogs were vaccinated against rabies within just two weeks. This vaccination drive aims to limit rabies transmission, demonstrating a preventive, public health-focused approach rather than reactive measures. BHUTAN The Kingdom of Bhutan has become the first country to achieve 100 percent sterilization of its free-roaming dog population under the Nationwide Accelerated Dog Population Management and Rabies Control Programme (NADPM & RCP), launched in March 2022 and completed in October 2023 at a cost of $3.55 million, according to World Organisation for Animal Health. Conducted in three phases, the initiative involved 12,812 personnel, including veterinarians, operating from 217 clinics across the country. A total of 61,680 dogs were sterilised, of which 91% were free-roaming AND PAKISTAN Turkey has enacted a law mandating the removal of millions of stray dogs, requiring municipalities to shelter, vaccinate, neuter, and offer dogs for adoption, with euthanasia permitted only for sick or dangerous Pakistan's Punjab province, a surge in dog attacks led authorities to cull 1,000 stray dogs within two weeks in March WHO SAYSAccording to the World Health Organisation (WHO), rabies causes an estimated 59,000 human deaths annually across more than 150 countries, primarily in Africa and Asia. In India, the disease claims between 18,000 to 20,000 lives each year, with children under 15 years old accounting for about 30-60% of these tragic human rabies deaths over 99 per cent, are caused by dog bites.- EndsMust Watch

Eli Lilly to raise UK price of weight-loss drug Mounjaro by 170%
Eli Lilly to raise UK price of weight-loss drug Mounjaro by 170%

Business Standard

time10 hours ago

  • Business Standard

Eli Lilly to raise UK price of weight-loss drug Mounjaro by 170%

Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White House push to get drugmakers to raise medicine prices in Europe to allow for price cuts in the United States. The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September. The price for a month's supply of the highest dose of the medicine will increase from £122 to £330, Lilly said. The higher price will affect those who pay for Mounjaro privately, but will not affect those prescribed the medicine through the British public healthcare system, which has a separate deal, a Lilly spokesperson said. The U.S. drugmaker said that when it launched Mounjaro in Britain it agreed to a list price "significantly below" that in its three other European markets to prevent delays in availability through Britain's National Health Service (NHS). "We are now aligning the list price more consistently," Lilly said. The move reflects how the pharmaceutical industry is navigating policy changes in the United States, by far its most lucrative market, where President Donald Trump is pushing for lower domestic prices and encouraging price hikes overseas. Last week Eli Lilly CEO David Ricks told an investor call that parity between U.S. and European drug pricing was desirable in the long run, though he warned that European governments "are not signing up to pay more for drugs". The U.S. pays more for prescription drugs than any other country, often nearly three times as much as other developed nations. Trump says he wants to narrow this gap to stop Americans from being "ripped off." Reuters reported last week that the Trump administration has been talking to drugmakers about ways to level the playing field for medicine prices. A list price is set by the drug manufacturer before any rebates or discounts. Lilly said it was working with private UK healthcare providers, such as online pharmacies, who can set their own prices, to ensure continued access to the medicines. Lilly launched Mounjaro in the UK in February last year, while rival Novo Nordisk's Wegovy treatment has been available in the country since September 2023.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store